A Study About the Safety of a Single ASP2020 Eye Injection and if it Helps People With Vision Loss From Stargardt-type Eye Conditions

NCT07734064 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Stargardt Disease
Stargardt Macular Dystrophy
Stargardt-like Macular Dystrophy

Interventions

DRUG: ASP2020

Sponsor

Astellas Institute for Regenerative Medicine